Jaktinib Hydrochloride Cream For Atopic Dermatitis

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

107

Participants

Timeline

Start Date

October 14, 2020

Primary Completion Date

September 8, 2022

Study Completion Date

September 8, 2022

Conditions

Atopic Dermatitis

Interventions

DRUG

Jaktinib Hydrochloride Cream

Subjects in each group were scheduled to give the drug for 8 weeks.

DRUG

Placebo

Trial Locations (1)

The Second Xiangya Hospital of Central South University, Changsha

All Listed Sponsors

lead

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

INDUSTRY

NCT04435392 - Jaktinib Hydrochloride Cream For Atopic Dermatitis | Biotech Hunter | Biotech Hunter